about
Resveratrol and Cardiovascular DiseasesInteractions between CYP3A4 and Dietary PolyphenolsResveratrol protects against polychlorinated biphenyl-mediated impairment of glucose homeostasis in adipocytesUse of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by StilbenesEffects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention.Inappropriate usage of dietary supplements in patients by miscommunication with physicians in Japan.Concomitant use of dietary supplements and medicines in patients due to miscommunication with physicians in Japan.Co-treatment with indole-3-carbinol and resveratrol modify porcine CYP1A and CYP3A activities and expression.Resveratrol Treatment after Status Epilepticus Restrains Neurodegeneration and Abnormal Neurogenesis with Suppression of Oxidative Stress and InflammationCombination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivoInhibition of cytochrome P450 3A by acetoxylated analogues of resveratrol in in vitro and in silico models.Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse ModelNatural polyphenols in the management of major depression.Resveratrol supplementation: Where are we now and where should we go?Significance of Resveratrol in Clinical Management of Chronic Diseases.Food Polyphenols Fail to Cause a Biologically Relevant Reduction of COX-2 Activity.Modulatory actions of o-coumaric acid on carcinogen-activating cytochrome P450 isozymes and the potential for drug interactions in human hepatocarcinoma cells.Pharmacological AMP kinase activators target the nucleolar organization and control cell proliferation.Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats.Safety of synthetic trans-resveratrol as a novel food pursuant to Regulation (EC) No 258/97Resveratrol Role in Autoimmune Disease-A Mini-Review.Effect of Resveratrol Treatment on the Pharmacokinetics of Diclofenac in Healthy Human Volunteers.Daily consumption of red grape cell powder in a dietary dose improves cardiovascular parameters: a double blind, placebo-controlled, randomized study.Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers.Resveratrol-Potential Antibacterial Agent against Foodborne Pathogens.Resveratrol: A Double-Edged Sword in Health Benefits
P2860
Q26752801-90967CC9-8B06-4737-B75B-415DE6CD41F6Q26800893-CC426663-F844-42DF-B88C-C1658B74281BQ28388408-06E80218-0224-4369-A02B-821BD45B013EQ28550408-4BD093BE-5985-4DF3-A4BF-E6B6A8D8AD45Q33771427-0022AFF9-E668-4982-B5A3-842CB060D140Q34774934-8BE85034-B910-432C-B314-18A142D648A3Q35586021-0727BF4F-9A90-45BB-96D2-286050BFA3ECQ36313788-73B77C03-1A58-4B16-BC00-D18A327A009BQ36350389-35CB047C-026A-4916-880B-55F25224488AQ36657133-D8FF0D36-5396-4499-9BC0-EEE5519594C6Q37181532-2B245058-D275-4F75-BA14-02D96FBC568AQ37387226-CA4DE32E-E457-42F6-A475-46493FE5E8C9Q38103949-42F78523-BDC8-4062-B7C9-76DD4A9CCDEFQ38334249-24DA3A02-A0E1-49FF-AC22-E573121D07FFQ38618547-0668FDD1-6135-4C14-B19F-8BBF2E050B23Q38830017-B7406B70-29D9-4C83-A848-55CA6754F571Q38886463-0C909E24-5AA4-4EC9-9E55-5D9C7CE27B22Q39026988-D845D19B-288A-4DE7-B6AA-AEC9AA09B8C0Q47098684-EC841237-BBCC-422F-92D6-E52425D92987Q47157595-EBF5D877-6C81-4986-BC85-639216516C35Q47158536-A3033315-8B49-4131-B98E-CC04B8C0E995Q48094701-A6D5D776-4B2A-40EC-8E44-0B151BED578AQ50452057-7555FA19-CF4F-424D-8AFC-FBD61E1B2A74Q51308824-AA3DC440-67B1-4582-93D8-1B12E9F689C2Q52668419-A21CC352-D1CA-45D9-9C30-7B37408A62D2Q58756915-3E196E5B-3CD8-4CA3-8806-F95BC4D372D4
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug interaction potential of resveratrol.
@en
type
label
Drug interaction potential of resveratrol.
@en
prefLabel
Drug interaction potential of resveratrol.
@en
P2093
P2860
P1476
Drug interaction potential of resveratrol
@en
P2093
Mareike Beck
Pascal Detampel
Stephan Krähenbühl
P2860
P304
P356
10.3109/03602532.2012.700715
P407
P50
P577
2012-08-01T00:00:00Z